Characterization and Quantitation of Aggregates and Particles in Interferon-β Products: Potential Links Between Product Quality Attributes and Immunogenicity-Reference-Cited by-同舟云学术

Characterization and Quantitation of Aggregates and Particles in Interferon-β Products: Potential Links Between Product Quality Attributes and Immunogenicity

Published:2013-03 Issue:3 Volume:102 Page:915-928
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Barnard James G.,Babcock Ken,Carpenter John F.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference42 articles.

1. On the role of aggregates in the immunogenicity of recombinant human interferon beta in patients withmultiple sclerosis;van Beers;J Interferon Cytokine Res,2010

2. Interferons at age 50: Past, current and future impact on biomedicine;Borden;Nat Rev Drug Discov,2007

3. Neutralising antibodies to interferon beta during the treatment of multiple sclerosis;Giovannoni;J Neurol Neurosurg Psychiatry,2002

4. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group;Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years;Neurology,1996

5. Frequency and magnitude of interferon beta neutralizing antibodies in the evaluation of interferon beta immunogenicity in patients with multiple sclerosis;Grossberg;J Interferon Cytokine Res,2011

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Protein-like Model Particles Fabricated by Micro 3D Printing to Established Standard Particles;Journal of Pharmaceutical Sciences;2024-08

2. Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics;Pharmaceutics;2024-04-30

3. Assessment of Imaging Flow Cytometry for the Simultaneous Discrimination of Protein Particles and Silicone Oil Droplets in Biologicals;Journal of Pharmaceutical Innovation;2024-03-01

4. Immunogenicity of Therapeutic Proteins;Pharmaceutical Biotechnology;2024

5. Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies;Journal of Pharmaceutical Sciences;2023-09